abstract |
Disclosed is a preparation of human immunoglobulin G useful for treatment. A human immunoglobulin G (IgG) is included, which contains at least 200 mM, preferably 250 mM ± 50 mM glycine, and 20 to 100 mg / l nonionic surfactant, and has a pH of 4.8 or less. A liquid pharmaceutical composition is provided. [Selection figure] None |